Rheumatology

Long-Term Monitoring & Quality of Life: Living with pSLE

At a Glance

Managing pediatric systemic lupus erythematosus (pSLE) long-term requires monitoring for permanent organ damage, cardiovascular issues, and bone conditions like avascular necrosis. Proactive screening for 'invisible' symptoms like fatigue and anxiety is crucial for preserving a child's quality of life.

Living with pediatric systemic lupus erythematosus (pSLE) is a marathon, not a sprint. Because pSLE is more aggressive than the adult version, the focus of care shifts from simply “putting out fires” (treating flares) to preventing the long-term, cumulative effects of the disease and its treatments ^[1]^[2].

Monitoring for Permanent Damage

One of the primary goals of your medical team is to minimize damage accrual—permanent changes to organs or tissues that cannot be reversed. Doctors track this using tools like the Systemic Lupus International Collaborating Clinics (SDI) Damage Index ^[3].

Bone Health and Avascular Necrosis (AVN): This is a condition where bone tissue dies due to a lack of blood flow, most commonly in the hips. The highest risks for AVN include major organ involvement (like kidney or brain disease) and high daily doses of corticosteroids ^[4].
Cardiovascular Health: Children with lupus are at an increased risk for early cardiovascular issues, including subclinical atherosclerosis (the early buildup of plaque in the arteries) ^[5]. Doctors may monitor vascular health using specialized tests like carotid intima-media thickness (CIMT) to look for these “silent” changes ^[6].

The “Invisible” Burden: Fatigue and Mental Health

For many children, the hardest parts of lupus are the symptoms that others cannot see. These factors are major drivers of a child’s Health-Related Quality of Life (HRQoL) ^[7].

Fatigue: Fatigue in pSLE is more than just being tired; it is a profound exhaustion that can interfere with school and play ^[8]. Routine assessment of fatigue is recommended to identify children at risk for poor long-term outcomes ^[7].
Anxiety and Depression: Mental health challenges are common comorbidities in pSLE ^[9]. Studies suggest that a significant number of children with lupus experience symptoms of depression or anxiety, which may go underdiagnosed without proactive screening ^[7]^[10].
Quality of Life Tools: Your team may use Patient-Reported Outcome Measures (PROMs), such as the PROMIS Pediatric measures, to allow your child to share their own experience with pain, fatigue, and physical activity ^[8]^[11]. This formally validates their “invisible” struggles as legitimate medical metrics that deserve attention.

Supporting Your Child’s Well-being

Beyond medication, non-pharmacologic approaches are becoming a standard part of “holistic” lupus care ^[12].

Physical Activity: Regular, supervised exercise has been shown to help improve fatigue, pain, and overall quality of life in children with lupus ^[13].
Psychological Support: Interventions such as cognitive-behavioral therapy or support groups can help children navigate the emotional toll of a chronic illness ^[14].

Because pSLE is aggressive, follow-up must be consistent. Even when your child looks and feels well, “silent” damage can occur ^[2]. Adhering to regular screenings for the heart, bones, and mental health is the best way to ensure your child reaches adulthood with the least amount of disease-related damage possible ^[15]^[16]. By working as a team with your child’s doctors and focusing on proactive care, you can help them achieve the best possible long-term outcomes.

Common questions in this guide

What is damage accrual in pediatric lupus?

Damage accrual refers to permanent, irreversible changes to organs or tissues caused by the disease or its treatments over time. Doctors monitor this closely using standardized scoring indexes to adjust care and prevent further harm.

Why is bone health closely monitored in children with pSLE?

Children with pSLE have a high risk of developing avascular necrosis, a condition where bone tissue dies due to lack of blood flow. This is most often caused by high daily doses of corticosteroids and major organ involvement.

How does pSLE affect a child's heart health?

Children with lupus have a higher risk of early cardiovascular issues, including the premature buildup of plaque in their arteries. Doctors may use specialized tests like carotid ultrasounds to monitor for these silent changes early on.

How can we manage my child's fatigue and mental health with pSLE?

Fatigue, anxiety, and depression are common invisible struggles for children with lupus. Working with the care team to use patient-reported outcome measures, encouraging supervised exercise, and providing therapy can significantly improve your child's well-being.

Curated prompts to bring to your next appointment.

1.What standardized tools (like PROMIS) do you use to screen for fatigue, anxiety, and depression during our visits?
2.What is our long-term plan to keep my child's cumulative steroid dose low to minimize the risk of avascular necrosis (AVN)?
3.Should we be performing 'silent' heart health screenings, such as checking carotid intima-media thickness (CIMT)?
4.How are we tracking 'damage accrual' over time, and what is my child's current score on the Damage Index (SDI)?
5.Can you recommend a physical activity plan or psychological support to help manage my child's fatigue and emotional well-being?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (16)

1
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.
Smith EMD, Aggarwal A, Ainsworth J, et al.
Annals of the rheumatic diseases 2023; (82(6)):788-798 doi:10.1136/ard-2022-223328.
PMID: 36627168
2
Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre.
Lim SC, Chan EWL, Tang SP
Lupus 2020; (29(9)):1106-1114 doi:10.1177/0961203320939185.
PMID: 32631203
3
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.
Holland MJ, Beresford MW, Feldman BM, et al.
Arthritis care & research 2018; (70(11)):1621-1629 doi:10.1002/acr.23531.
PMID: 29409150
4
Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
Yang Y, Kumar S, Lim LS, et al.
The Journal of rheumatology 2015; (42(12)):2304-9 doi:10.3899/jrheum.150464.
PMID: 26568601
5
Early Atherosclerosis in Pediatric Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Patra PK, Banday AZ, Asghar A, et al.
International journal of rheumatic diseases 2025; (28(4)):e70217 doi:10.1111/1756-185X.70217.
PMID: 40207667
6
Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
Barsalou J, Bradley TJ, Tyrrell PN, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(1)):237-46 doi:10.1002/art.39423.
PMID: 26361097
7
Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus.
Donnelly C, Cunningham N, Jones JT, et al.
Lupus 2018; (27(1)):124-133 doi:10.1177/0961203317716317.
PMID: 28662595
8
Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease.
Zigler CK, Li Z, Hernandez A, et al.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2024; (33(12)):3449-3457 doi:10.1007/s11136-024-03800-2.
PMID: 39400691
9
Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review.
Quilter MC, Hiraki LT, Korczak DJ
Lupus 2019; (28(7)):878-887 doi:10.1177/0961203319853621.
PMID: 31188723
10
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update.
Unal D, Cam V, Emreol HE, Özen S
Paediatric drugs 2024; (26(4)):381-395 doi:10.1007/s40272-024-00632-y.
PMID: 38805115
11
Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care.
Nguyen MH, Huang FF, O'Neill SG
Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163754.
PMID: 34442047
12
Psychiatric manifestations of systemic lupus erythematosus: A brief review with two case-reports.
Kassim FM, Wordefo DK, Berhanu M, et al.
SAGE open medical case reports 2024; (12()):2050313X241229010 doi:10.1177/2050313X241229010.
PMID: 38313038
13
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review.
Ross E, Abulaban K, Kessler E, Cunningham N
Lupus 2022; (31(7)):864-879 doi:10.1177/09612033221094704.
PMID: 35442103
14
Non-pharmacologic therapies for systemic lupus erythematosus.
Fangtham M, Kasturi S, Bannuru RR, et al.
Lupus 2019; (28(6)):703-712 doi:10.1177/0961203319841435.
PMID: 30961418
15
Quality of Care in Childhood-onset Systemic Lupus Erythematosus: Report of an Intervention to Improve Cardiovascular and Bone Health Screening.
Smitherman EA, Huang B, Furnier A, et al.
The Journal of rheumatology 2020; (47(10)):1506-1513 doi:10.3899/jrheum.190295.
PMID: 31474591
16
Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
Harris JG, Maletta KI, Kuhn EM, Olson JC
Clinical rheumatology 2017; (36(2)):351-359 doi:10.1007/s10067-016-3518-0.
PMID: 28013435

This page provides educational information on long-term monitoring and quality of life for pSLE. It does not replace professional medical advice from your child's pediatric rheumatologist.

Get notified when new evidence is published on Pediatric systemic lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents